Literature DB >> 17984433

Does the biocompatibility of the peritoneal dialysis solution matter in assessment of peritoneal function?

Alena Parikova1, Dirk G Struijk, Machteld M Zweers, Monique Langedijk, Natalie Schouten, Nicole van den Berg, Saskia Duis, Raymond T Krediet.   

Abstract

BACKGROUND: Peritoneal function tests are performed in peritoneal dialysis (PD) patients to characterize peritoneal membrane status. A low pH/high glucose degradation product (GDP) dialysis solution is used as the test solution. The objective of the present study was to compare a 3.86% glucose, low pH/high GDP dialysis solution (pH 5.5) with a 3.86% glucose, normal pH/low GDP dialysis solution (pH 7.4) in assessments of peritoneal membrane function.
METHODS: Two standard peritoneal permeability analyses (SPA) were performed in 10 stable PD patients within 2 weeks. One SPA was done with the 3.86% low pH/high GDP solution, and the other with the 3.86% normal pH/low GDP solution. The sequence of the two tests was randomized.
RESULTS: Fluid transport parameters and glucose absorption were not different between the two groups. No differences were found for the mass transfer area coefficients (MTACs) of low molecular weight solutes calculated over the whole dwell. However, MTAC urea in the first hour of the dwell was higher in the test done with low pH/high GDP dialysate, suggesting more peritoneal vasodilation. No difference was found in protein clearances. Sodium sieving at multiple time points during the dwell was similar with the two solutions.
CONCLUSION: The results obtained with the glucose-containing normal pH/low GDP dialysis solution were similar to those obtained with the glucose-containing low pH/high GDP dialysate in assessments of peritoneal membrane function.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17984433

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  7 in total

Review 1.  Encapsulating peritoneal sclerosis in children.

Authors:  Constantinos J Stefanidis; Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2013-11-21       Impact factor: 3.714

2.  Utility of Urinary Biomarkers in Predicting Loss of Residual Renal Function: The balANZ Trial.

Authors:  Yeoungjee Cho; David W Johnson; David A Vesey; Carmel M Hawley; Margaret Clarke; Nicholas Topley
Journal:  Perit Dial Int       Date:  2014-04-07       Impact factor: 1.756

3.  The Association of Effluent Ca125 with Peritoneal Dialysis Technique Failure.

Authors:  Deirisa Lopes Barreto; Tiny Hoekstra; Nynke Halbesma; Martijn Leegte; Elisabeth W Boeschoten; Friedo W Dekker; Raymond T Krediet
Journal:  Perit Dial Int       Date:  2015-07-07       Impact factor: 1.756

4.  Correlation between Ultrafiltration Coefficient and Effective Lymphatic Absorption Rate in Continuous Ambulatory Peritoneal Dialysis Patients: A Possible Paradigm Shift.

Authors:  Reza Hekmat
Journal:  Iran J Med Sci       Date:  2019-07

5.  Biocompatible peritoneal dialysis fluids: clinical outcomes.

Authors:  Yeoungjee Cho; Sunil V Badve; Carmel M Hawley; Kathryn Wiggins; David W Johnson
Journal:  Int J Nephrol       Date:  2012-11-28

6.  Biocompatible dialysis fluids for peritoneal dialysis.

Authors:  Htay Htay; David W Johnson; Kathryn J Wiggins; Sunil V Badve; Jonathan C Craig; Giovanni Fm Strippoli; Yeoungjee Cho
Journal:  Cochrane Database Syst Rev       Date:  2018-10-26

7.  Peritoneal function in clinical practice: the importance of follow-up and its measurement in patients. Recommendations for patient information and measurement of peritoneal function.

Authors:  Annemieke M Coester; Watske Smit; Dirk G Struijk; Raymond T Krediet
Journal:  NDT Plus       Date:  2009-01-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.